oxymorphol oxymorphol oxymorphol is oxymorphone which has been hydrogenated at the 6-position and consists of a mixture of 4,5α-epoxy-17-methylmorphinan-3,6β,14-triol and 4,5α-epoxy-17-methylmorphinan-3,6α,14-triol (hydromorphinol). it is produced by the human body as an active metabolite of oxymorphone and some bacteria as an intermediate in turning morphine into hydromorphone. it can also be manufactured and is the subject of patents by drug companies looking for new semi-synthetic analgesics and cough suppressants. oxymorpholclinical dataother names4,5α-epoxy-17-methylmorphinan-3,6,14-triolatc coden02a (who) pharmacokinetic datametabolismhepaticidentifiers iupac name (5α)-17-methyl-4,5-epoxymorphinan-3,6,14-triol cas number54934-75-7pubchem cid6712731chemspider5144767unii67p6d5q6ykchemblchembl1968360 ychemical and physical dataformulac17h21no4molar mass303.358 g·mol−13d model (jsmol)interactive image smiles cn1cc23c4c5ccc(c4o2c(cc3(1c5)o)o)o inchi inchi=1s/c17h21no4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,11-12,15,19-21h,4-8h2,1h3/t11?,12-,15+,16+,17-/m1/s1 ykey:aablhgpvoulici-zofkvtqnsa-n y a derivative of oxymorphol, 8-hydroxy-6-α-oxymorphol, was discovered in the first decade of the 21st century and the subject of a patent application by endo pharmaceuticals for an analgesic and antitussive.